Friedrich W. Mohr focuses on Surgery, Internal medicine, Cardiology, Percutaneous coronary intervention and Aortic valve. The Surgery study combines topics in areas such as Aortic valve replacement and Revascularization. The Cardiology study which covers Hazard ratio that intersects with Mortality rate.
Percutaneous coronary intervention is frequently linked to Conventional PCI in his study. The concepts of his Aortic valve study are interwoven with issues in EuroSCORE, Stenosis, Extracorporeal circulation and Prosthesis. His work focuses on many connections between Angioplasty and other disciplines, such as Hybrid coronary revascularization, that overlap with his field of interest in Bypass surgery.
His scientific interests lie mostly in Surgery, Internal medicine, Cardiology, Aortic valve and Cardiac surgery. His work deals with themes such as Cardiopulmonary bypass and Aortic valve replacement, which intersect with Surgery. His study in Percutaneous coronary intervention, Coronary artery disease, Artery, Revascularization and Coronary artery bypass surgery falls within the category of Internal medicine.
His biological study spans a wide range of topics, including Stroke, Stent, Angioplasty and Hazard ratio. Stenosis, Myocardial infarction, Conventional PCI, Ejection fraction and Hemodynamics are the core of his Cardiology study. Friedrich W. Mohr combines subjects such as Transcatheter aortic, EuroSCORE and Prosthesis with his study of Aortic valve.
His primary scientific interests are in Internal medicine, Cardiology, Surgery, Aortic valve and Percutaneous coronary intervention. Coronary artery disease, Revascularization, Hazard ratio, Coronary artery bypass surgery and Cardiac surgery are the primary areas of interest in his Internal medicine study. His research investigates the connection between Cardiology and topics such as Stroke that intersect with problems in Randomized controlled trial and Clinical endpoint.
His Surgery study integrates concerns from other disciplines, such as Stenosis and Aortic valve replacement. His study looks at the relationship between Aortic valve and fields such as Endocarditis, as well as how they intersect with chemical problems. His Percutaneous coronary intervention research is multidisciplinary, relying on both Calcification, Stent, Conventional PCI and Infarction.
Friedrich W. Mohr mostly deals with Internal medicine, Cardiology, Surgery, Stroke and Aortic valve. Friedrich W. Mohr regularly ties together related areas like Hazard ratio in his Cardiology studies. His research integrates issues of Cardiopulmonary bypass and Aortic valve replacement in his study of Surgery.
His research in Stroke intersects with topics in Clinical endpoint and Bypass grafting. His study in Aortic valve is interdisciplinary in nature, drawing from both Quality of life and Valve replacement. His Percutaneous coronary intervention research is multidisciplinary, incorporating elements of Stent and Conventional PCI.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
Patrick W. Serruys;Marie-Claude Morice;A. Pieter Kappetein;Antonio Colombo.
The New England Journal of Medicine (2009)
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease : 5-year follow-up of the randomised, clinical SYNTAX trial
Friedrich W. Mohr;Marie Claude Morice;A. Pieter Kappetein;Ted E. Feldman.
The Lancet (2013)
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
Vasim Farooq;David Van Klaveren;Ewout W. Steyerberg;Emanuele Meliga.
The Lancet (2013)
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman.
Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients.
Jan Bucerius;Jan F Gummert;Michael A Borger;Thomas Walther.
The Annals of Thoracic Surgery (2003)
Transapical Minimally Invasive Aortic Valve Implantation Multicenter Experience
Thomas Walther;Paul Simon;Todd Dewey;Gerhard Wimmer-Greinecker.
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial
Arie Pieter Kappetein;Ted E. Feldman;Michael J. MacK;Marie Claude Morice.
European Heart Journal (2011)
Assessment of the SYNTAX score in the Syntax study
Patrick W. Serruys;Yoshinobu Onuma;Scot Garg;Giovanna Sarno.
Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock
Ardawan Julian Rastan;Andreas Dege;Matthias Mohr;Nicolas Doll.
The Journal of Thoracic and Cardiovascular Surgery (2010)
Computer-enhanced "robotic" cardiac surgery: experience in 148 patients
Friedrich W. Mohr;Volkmar Falk;Anno Diegeler;Thomas Walther.
The Journal of Thoracic and Cardiovascular Surgery (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: